(HealthDay News) For fetuses, newborns, and infants, whole-body, post-mortem magnetic resonance imaging (MRI) has similar accuracy to conventional autopsy for detection of the cause of death, according to a study published in The Lancet. "Minimally invasive autopsy has accuracy similar to that of conventional autopsy for detection of cause of death or major pathological abnormality after death," the authors write. MAY. 17, 2013
RESEARCH NEWS
(HealthDay News) Neither evening primrose oil (EPO) nor borage oil (BO) are effective at treating eczema, according to a literature review of 27 studies published in The Cochrane Library. Of the 27 studies, 19 assessed EPO, while eight studies assessed BO. Seven studies included in a meta-analysis showed that EPO failed to significantly increase improvement in global eczema symptoms. MAY. 16, 2013
RESEARCH NEWS
(HealthDay News) Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria for identifying patients with a disease requiring methotrexate (MTX) treatment, according to research published in Arthritis & Rheumatism. MAY. 15, 2013
RESEARCH NEWS
(HealthDay News) Combination therapy with teriparatide and denosumab may be most effective in treating postmenopausal women with osteoporosis at risk for fracture, according to a study published in The Lancet. "Combined teriparatide and denosumab increased BMD more than either agent alone and more than has been reported with approved therapies," the authors write. MAY. 15, 2013
PHARMA INDUSTRY NEWS
(HealthDay News) "Because of an increasing prevalence, adult spinal deformity (ASD) is emerging as a challenging health care issue of the 21st century. Management of ASD patients and selection of fusion levels remain controversial," the authors write in The Spine Journal. "The development of a widely accepted classification system will help to share knowledge and improve our ability to treat these complex clinical situations." MAY. 14, 2013
RESEARCH NEWS
(HealthDay News) Americans with COPD may have new help in their quest to breathe better, with the approval of the combination drug Breo Ellipta. The drug's safety and effectiveness were clinically evaluated in some 7,700 people with COPD. Common side effects included nasal inflammation, upper respiratory infection, and headache. MAY. 14, 2013
RESEARCH NEWS
